PROC logo

Procaps Group SA (PROC)

Profile

Full Name

Procaps Group S.A.

Ticker Symbol

PROC

Exchange

NASDAQ

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Country

Luxembourg

IPO

December 9, 2019

Indexes

Not included

Website

http://www.procapsgroup.com

Employees

5500

Key Details

Price

$1.45(0.00%)

Market cap

$163.60M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$409.92M(+0.04% YoY)

Annual EPS

$0.42(+140.78% YoY)

PE ratio

2.79

Next earnings date

N/A

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$1.45
PROC price is $1.45

30-Day Relative Volume

0.00
PROC 30-day relative volume is 0.00

Price Performance

Price Most recent change

0%
PROC {parameterFullLabel} has remained unchanged on Apr 16, 2025

Price YTD change

-38.03%
PROC price is down -38.03% since January 1st

Price 1-year change

-43.36%
PROC price is down -43.36% year-on-year

Price 3-year change

-81.88%
PROC price is down -81.88% over the past 3 years

Price Range

Price All-time high

$11.98
PROC price is currently -87.90% below its historical high of $11.98

Price 3-year low

$0.50
PROC price is currently +190.00% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$163.60M
PROC market capitalization is $163.60 million

Market cap 3-year change

-81.88%
PROC market capitalization is down -81.88% over the past 3 years

Market cap All-time high

$1.18B
PROC market capitalization is currently -86.08% below its historical high of $1.18 billion

Market cap sector rank

54.93%
PROC market capitalization is higher than 54.93% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

0%
PROC {parameterFullLabel} has remained unchanged year-on-year

Shares Outstanding 3-Year Change

0%
PROC {parameterFullLabel} has remained unchanged over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.31
PROC beta is 0.31

200-day SMA

$1.78
PROC price is currently -18.48% below its 200-day simple moving average

50-day SMA

$1.21
PROC price is currently +19.97% above its 50-day simple moving average

RSI

53.18
PROC 14-day relative strength index is 53.18

Volume

0.00
PROC 30-day relative volume is 0.00

ATR

$0.16
PROC average true range is $0.16

10-day Historical Volatility

962.32%
PROC 10-day historical volatility is 962.32%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$409.92M
PROC annual revenue is $409.92 million

Revenue Analysts estimate

$424.15M
PROC annual revenue is currently -3.35% lower than the consensus analysts' forecast

Revenue 1-year change

+0.04%
PROC annual revenue is up +0.04% year-on-year

Revenue Sector rank

72%
PROC annual revenue is higher than 72% of companies in Healthcare sector

EPS

EPS

$0.42
PROC annual earnings per share is $0.42

EPS Analysts estimate

-
PROC annual earnings per share consensus analysts' forecast is unknown

EPS 1-year change

+140.78%
PROC annual earnings per share is up +140.78% year-on-year

EPS Sector rank

86.69%
PROC annual earnings per share is higher than 86.69% of companies in Healthcare sector

Profit

Gross profit

$239.57M
PROC annual gross profit is $239.57 million

Gross margin

58.44%
PROC annual gross profit margin is 58.44%

Operating profit

$40.09M
PROC annual operating income is $40.09 million

Operating margin

9.78%
PROC annual operating profit margin is 9.78%

Net income

$42.54M
PROC annual net profit is $42.54 million

Net margin

10.38%
PROC annual net profit margin is 10.38%

Expenses

Total expenses

$369.83M
PROC annual total expenses is $369.83 million

Operating expenses

$199.48M
PROC annual total operating expenses is $199.48 million

Cost of goods sold

$170.35M
PROC annual cost of goods sold is $170.35 million

Selling, general & administrative expenses

$199.48M
PROC annual SGA is $199.48 million

Depreciation and amortization

$16.84M
PROC annual depreciation & amortization is $16.84 million

Interest expense

$25.76M
PROC annual interest expense is $25.76 million

Income tax

$10.17M
PROC annual income tax is $10.17 million

EBIT & EBITDA

EBIT

$78.47M
PROC annual earnings before interest & taxes is $78.47 million

EBITDA

$95.32M
PROC annual EBITDA is $95.32 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$460.19M
PROC annual total assets is $460.19 million

Non current assets

$162.74M
PROC annual long term assets is $162.74 million

Current assets

$297.44M
PROC annual total current assets is $297.44 million

Cash and cash equivalents

$43.00M
PROC annual cash & cash equivalents is $43.00 million

Accounts receivable

$141.67M
PROC annual accounts receivable is $141.67 million

Inventory

$96.83M
PROC annual inventory is $96.83 million

Liabilities

Total liabilities

$462.06M
PROC annual total liabilities is $462.06 million

Long term liabilities

$93.69M
PROC annual total long term liabilities is $93.69 million

Current liabilities

$368.37M
PROC annual total current liabilities is $368.37 million

Accounts payable

$81.48M
PROC annual accounts payable is $81.48 million

Debt

Total debt

$285.94M
PROC annual total debt is $285.94 million

Total debt 1-year change

+12.85%
PROC annual total debt is up +12.85% year-on-year

Long term debt

$28.41M
PROC annual long term debt is $28.41 million

Short term debt

$257.52M
PROC annual short term debt is $257.52 million

Equity & Capital

Shareholders equity

-$941.00K
PROC annual stockholders equity is -$941.00 thousand

Book value

-$941.00K
PROC annual book value is -$941.00 thousand

Retained earnings

-$391.51M
PROC annual retained earnings is -$391.51 million

Working capital

-$70.93M
PROC annual working capital is -$70.93 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

$14.11M
PROC annual cash flow from operations is $14.11 million

Cash from operations 1-year change

-62.19%
PROC annual cash flow from operations is down -62.19% year-on-year

Cash from investing

-$28.83M
PROC annual cash flow from investing activities is -$28.83 million

Cash from investing 1-year change

-21.62%
PROC annual cash flow from investing activities is down -21.62% year-on-year

Cash from financing

-$13.63M
PROC annual cash flow from financing activities is -$13.63 million

Cash from financing 1-year change

-123.48%
PROC annual cash flow from financing activities is down -123.48% year-on-year

CAPEX

CAPEX

$31.57M
PROC annual capital expenditures is $31.57 million

CAPEX 1-year change

+28.75%
PROC annual capital expenditures is up +28.75% year-on-year

Free Cash Flow

Free cash flow

-$17.47M
PROC annual free cash flow is -$17.47 million

Free cash flow 1-year change

-236.71%
PROC annual free cash flow is down -236.71% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

58.44%
PROC annual gross profit margin is 58.44%

Operating margin

9.78%
PROC annual operating profit margin is 9.78%

Net margin

10.38%
PROC annual net profit margin is 10.38%

ROA & ROE

ROA

9.22%
PROC annual return on assets is 9.22%

ROE

-4520.72%
PROC annual return on equity is -4520.72%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

2.79
PROC price to earnings ratio is 2.79

PE ratio Sector rank

4.41%
PROC price to earnings ratio is higher than 4.41% of companies in Healthcare sector

PB Ratio

PB ratio

4.15
PROC price to book ratio is 4.15

PB ratio Sector rank

80.23%
PROC price to book ratio is higher than 80.23% of companies in Healthcare sector

PS Ratio

PS ratio

0.40
PROC price to sales ratio is 0.40

PS ratio Sector rank

14.23%
PROC price to sales ratio is higher than 14.23% of companies in Healthcare sector

Enterprise value

Enterprise value

$435.96M
PROC enterprise value is $435.96 million

Enterprise value Sector rank

68.21%
PROC enterprise value is higher than 68.21% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

3.53
PROC EV/EBITDA is 3.53

EV/EBITDA Sector rank

77.3%
PROC EV/EBITDA is higher than 77.3% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

0.81
PROC annual current ratio is 0.81

Quick ratio

0.54
PROC annual quick ratio is 0.54

Leverage

Debt to equity

-303.86
PROC annual debt to equity ratio is -303.86

Interest coverage ratio

3.05
PROC annual interest coverage ratio is 3.05

Risk & Stability

Piotroski F-Score

6
PROC piotroski f-score is 6

Altman Z-Score

0.29
PROC altman z-score is 0.29

Analyst ratings

Recent major analysts updates

Sep 6, 23 Brookline Capital
Hold

Institutional Ownership

Similar stocks

American Oncology Network (AONC)
Aardvark Therapeutics (AARD)
IPHA logo
Innate Pharma SA (IPHA)
LNSR logo
LENSAR (LNSR)
FULC logo
Fulcrum Therapeutics (FULC)
INBX logo
Inhibrx Biosciences (INBX)
NGNE logo
Neurogene (NGNE)
Actuate Therapeutics (ACTU)
CVRX logo
CVRx (CVRX)
  • What is the ticker symbol for Procaps Group SA?
  • Does Procaps Group SA pay dividends?
  • What sector is Procaps Group SA in?
  • What industry is Procaps Group SA in?
  • What country is Procaps Group SA based in?
  • When did Procaps Group SA go public?
  • Is Procaps Group SA in the S&P 500?
  • Is Procaps Group SA in the NASDAQ 100?
  • Is Procaps Group SA in the Dow Jones?
  • When was Procaps Group SA's last earnings report?
  • When does Procaps Group SA report earnings?
  • Should I buy Procaps Group SA stock now?

What is the ticker symbol for Procaps Group SA?

The ticker symbol for Procaps Group SA is NASDAQ:PROC

Does Procaps Group SA pay dividends?

No, Procaps Group SA does not pay dividends

What sector is Procaps Group SA in?

Procaps Group SA is in the Healthcare sector

What industry is Procaps Group SA in?

Procaps Group SA is in the Drug Manufacturers - Specialty & Generic industry

What country is Procaps Group SA based in?

Procaps Group SA is headquartered in Luxembourg

When did Procaps Group SA go public?

Procaps Group SA's initial public offering (IPO) was on December 9, 2019

Is Procaps Group SA in the S&P 500?

No, Procaps Group SA is not included in the S&P 500 index

Is Procaps Group SA in the NASDAQ 100?

No, Procaps Group SA is not included in the NASDAQ 100 index

Is Procaps Group SA in the Dow Jones?

No, Procaps Group SA is not included in the Dow Jones index

When was Procaps Group SA's last earnings report?

Procaps Group SA's most recent earnings report was on Feb 5, 2025

When does Procaps Group SA report earnings?

The date for Procaps Group SA's next earnings report has not been announced yet

Should I buy Procaps Group SA stock now?

As of today, analysts generally recommend a 'Hold' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page